Results 91 to 100 of about 7,515,536 (268)

Degree-days: An introduction

open access: yes, 2020
Introduction to a more precise method of describing physiological development, growth stages, and maturity by defining accumulated degree-days known as ''growing degree-days'' (GDD)
Ball, Shane T.
core  

Fifty-six-year trends (1953–2008) in growing season length, first autumn frost, last spring frost, and growing degree days.

open access: yes, 2012
Fifty-six-year trends (1953–2008) in growing season length, first autumn frost, last spring frost, and growing degree days.
Robert P. Guralnick (76182)   +3 more
core   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Cotton crop irrigation planning (Gossypium hirsutum L.) through an integral programming model at 075 District, Sinaloa, Mexico

open access: yesScientia Agropecuaria, 2014
Cotton crops were one of the most important during the 50 and 80 decades in Northern Sinaloa, Mexico from the economical point of view. However, external factors such as monoculture and sanitary issues caused its disappearance.
Ernesto Sifuentes Ibarra   +4 more
doaj   +1 more source

Twenty-year trends (1998–2008) in growing season length, first autumn frost, last spring frost, and growing degree days.

open access: yes, 2012
Twenty-year trends (1998–2008) in growing season length, first autumn frost, last spring frost, and growing degree days.
Robert P. Guralnick (76182)   +3 more
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Development of Prediction Growth and Yield Models by Growing Degree Days in Hot Pepper

open access: yesProtected horticulture and Plant Factory, 2018
This study was carried out to estimate growth characteristics of hot pepper and to develop predicted models for the production yield based on the growth parameters and climatic elements.
Sung Kyeom Kim   +6 more
semanticscholar   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy